Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
Sheikh Sāleḥ bin Fawzān bin ‘Abd Allāh al-Fawzān (born 28 September 1935) is a Saudi Islamic scholar who is the fourth and current Grand Mufti of Saudi Arabia, serving since 22 October 2025. He is regarded as one of the senior scholars within the Salafi movement. Al-Fawzan is also a member of Saudi Arabia's Council of Senior Scholars and the fiqh council in Mecca, affiliated with the Muslim World League. He also serves as a member of the Supervisory Committee for Preachers during Hajj, and a member of the Permanent Committee for Scholarly Research and Ifta in the Saudi Arabia. In addition to this, he is an imam, khatib and teacher at the Prince Mutaib bin Abdulaziz Al Saud Mosque in Riyadh. He participates in the radio program Nūr 'Alā al-Darb, answering questions on Islamic topics, and contributes to scholarly journals in the form of research, studies, letters, and fatwas.
Calmodulin is an example of a signal-transduction protein. It is a small protein that contains four EF-hand motifs, each of which is able to bind a Ca2+ ion. In an EF-hand loop protein domain, the calcium ion is coordinated in a pentagonal bipyramidal configuration. Six glutamic acid and aspartic acid residues involved in the binding are in positions 1, 3, 5, 7 and 9 of the polypeptide chain. At position 12, there is a glutamate or aspartate ligand that behaves as a bidentate ligand, providing two oxygen atoms. The ninth residue in the loop is necessarily glycine due to the conformational requirements of the backbone. The coordination sphere of the calcium ion contains only carboxylate oxygen atoms and no nitrogen atoms. This is consistent with the hard nature of the calcium ion. The protein has two approximately symmetrical domains, separated by a flexible "hinge" region. Binding of calcium causes a conformational change to occur in the protein. Calmodulin participates in an intracellular signaling system by acting as a diffusible second messenger to the initial stimuli.
In short, information about the possible existence of an extraterrestrial civilization would come in the form of electromagnetic radiation. With regard to the fate of civilizations, Kardashev saw two concepts, from which two strategies for the search for extraterrestrial civilizations can be derived. The first, which he called "terrestrial chauvinism", is based on the principle that civilizations can only stabilize or perish at a level of development close to ours currently reached. The second, which he called the "evolutionary concept", holds that civilizations are capable of reaching higher levels of development than that of contemporary humanity. In the first case, the best search strategy using astronomical detection means (e.g., the SETI program) would be to observe the most powerful (and often the most distant) sources of radiation in space. The observer will then be able to determine if they are natural emission sources, and only then can the search focus on objects with weaker radiation. In the second case, he recommended to search for new and powerful sources of radiation, especially in the poorly known regions of the electromagnetic spectrum. These sources could be significant or periodic monochromatic signals from the galactic center, from other galaxies or from quasars and other exotic cosmic objects. Kardashev believed that the search should focus on the millimeter wavelength spectrum, close to the maximum intensity of the cosmic microwave background, rather than in the 21-centimeter band (which is the domain of investigation of the SETI program).
=== CSIR India === In 2009, Ayyadurai was hired by India's Council of Scientific and Industrial Research (CSIR), India's largest science agency, by its director general, Samir K. Brahmachari. CSIR was mandated to create a new company, CSIR Tech, that would establish businesses using the research conducted by the country's many publicly owned laboratories. Ayyadurai reported that he had spent months trying to create a business plan for CSIR Tech, but received no response from Brahmachari. Ayyadurai then distributed a draft plan, which was not authorized by CSIR, to the agency's scientists that requested feedback and criticized management. His job offer was subsequently withdrawn five months after the position was offered. Brahmachari said that "the offer was withdrawn as [Ayyadurai] did not accept the terms and conditions and demanded unreasonable compensation." In its report, The New York Times said that "going public with such accusations is highly unusual. Mr. Ayyadurai circulated his paper not just to the agency's scientists but to journalists, and wrote about his situation to Prime Minister Manmohan Singh." In that letter, Ayyadurai said his report was intended to explore institutional barriers to CSIR's entrepreneurial mandate. He said that CSIR scientists reported that "they work in a medieval, feudal environment" that required a "major overhaul". The letter was co-authored by a colleague, Deepak Sardana.
Sources: en.wikipedia.org
The Orange Box is a video game compilation containing five games developed and published by Valve. Two of the games included—Half-Life 2 and its first stand-alone expansion, Episode One—had previously been released in 2004 and 2006 as separate products. Three new games were also included in the compilation: the second stand-alone expansion, Half-Life 2: Episode Two; the puzzle game Portal; and Team Fortress 2, the sequel to Team Fortress Classic. Valve also released a soundtrack containing music from the games within the compilation. A separate product entitled The Black Box was planned, which would have included only the new games, but was later canceled. The Orange Box was released for Windows and the Xbox 360 in October 2007, while the PlayStation 3 version, developed by EA UK, was released in December 2007. The Xbox 360 and PlayStation 3 versions were published by Electronic Arts. A digital Orange Box pack, containing the five games, was released in May 2010 for Mac OS X following the release of Steam for the platform, while a similar version for Linux followed after the Steam's clients release for Linux in early 2013. The Orange Box received widespread critical acclaim, with Portal being recognized as a surprise favorite of the package. The PlayStation 3 version of The Orange Box, however, was criticized for containing several technical shortcomings that were not present in the other versions, only a few of which were fixed through a single patch.
, where WU is water use in kg/day, M is mass of deuterated water injected in grams, T is the final day of the experiment, Ci is concentration of deuterium at time interval i in grams/kilogram, and Δti is the length of time interval i in days. Though the calculated water use via thermal-dissipation-probing of some tropical plants such as bamboos, correlates strongly with measured water use found by tracking D2O movement, the exact values are not the same. In fact, with the legume tree Gliricidia sepium, which produces a heartwood, transpired water did not even correlate strongly with injected 2H2O concentrations, which would further complicate water use measurements from direct injections. This possibly occurred because heartwoods could accumulate heavy water rather than move the water directly through xylem and to leaves. WUE, the ratio of carbon fixation to transpiration, has previously been associated with 13C/12C ratios using the equation:
The People's Party (PP) held the government under the presidency of José María Aznar for eight years. During his first term (1996–2000), having failed to obtain an absolute majority, the PP had to rely on the support of the CiU Catalan nationalists to govern, but in his second term (2000–2004) he had no need for pacts having obtained an absolute majority in the general election of March 2000.
=== Wound healing and immunomodulation === In preliminary research, oat β-glucan is being studied for its potential immunomodulatory effects, antitumour properties, and stimulation of collagen deposition, tissue granulation, reepithelization, and macrophage infiltration in the wound healing process.
== Invertebrates == It is less common to find examples of dedifferentiation (due to a lack of regenerative ability) in most invertebrates. This brief example outlines dedifferentiation in an invertebrate species, and interestingly involves the Msx pathway, as detailed above in the mechanisms section.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.